Efficacy and safety of drug-eluting balloon-only strategy (DEB-only) for de novo coronary artery disease: a systematic review and meta-analysis

28 August 2020 (08:00 - 18:00)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Wen-Yi Zhang

Beijing (China)

174 More presentations in this session

Presentation thumbnail

Clinical profile and predictors of positivity of acetylcholine test in patients with angina and no obstructive coronary artery disease. Results of a multi-center mediterranean registry.

Doctor L. Grigorian (Madrid, ES)

Abstract Slides

Presentation thumbnail

Comparison of neointimal coverage between biodegradable-polymer everolimus-eluting stent and durable-polymer everolimus-eluting stent using angioscopy for the patients with acute coronary syndrome

Assistant Professor T. Umemoto (Tokyo, JP)

Abstract Slides

Presentation thumbnail

Global risk factors of contrast-Induced acute kidney injury: systematic review and meta-analysis

Doctor L. Liu (Shanghai, CN)

Abstract Slides

Presentation thumbnail

Post-procedural quantitative flow ratio gradient and target lesion revascularization after drug-coated balloon or plain-old balloon angioplasty

Doctor H. Kirigaya (Yokohama, JP)

Abstract Slides

Presentation thumbnail

Hyperemic hemodynamic characteristics of serial coronary lesions assessed by pressure pullbacks gradients (PPG) index.

Doctor A. Candreva (Zurich, CH)

Abstract Slides

Access the full session

Session thumbnail

Interventional Cardiology ePosters

The Event

ESC Congress 2020

28 August 2020 08:00 CET

You may be interested in

Congress Presentation

'My bleeding heart': tamponade – detection and management

Congress Session

Complex PCI in practice: tips and tricks to take home

Congress Presentation

An uneventful triade – a case report of an extensive iatrogenic coronary dissection

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources